Inhibition of monoamine oxidase B by selective adenosine A 2A receptor antagonists
- 1 February 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (7) , 1299-1310
- https://doi.org/10.1016/s0968-0896(02)00648-x
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from TobaccoChemical Research in Toxicology, 2001
- Inhibition of Monoamine Oxidase Contributes to the Protective Effect of 7‐Nitroindazole Against MPTP NeurotoxicityJournal of Neurochemistry, 1997
- The Neuronal Nitric Oxide Synthase Inhibitor 7-Nitroindazole Also Inhibits the Monoamine Oxidase-B-Catalyzed Oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineChemical Research in Toxicology, 1997
- Neuroprotective Therapy for Parkinson's DiseaseExperimental Neurology, 1997
- Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeurodegeneration, 1995
- Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH DehydrogenaseJournal of Neurochemistry, 1991
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984